Sandoz Inc, a Germany-based company that develops, manufactures, and distributes generic pharmaceutical products, has signed a long-term agreement with Civica Rx, a United States-based non-profit organisation that seeks to make quality generic medicines available and affordable to its hospital members, it was reported on Tuesday.
The contract has been signed to produce and provide critical injectable generic medicines, in order to decrease supply shortages in US hospitals and ensure that acute care settings can deliver optimal patient care.
According to the five-year contract, Sandoz Inc is to provide six injectable medicines, including antibiotics, acid reducers, blood thinners, blood pressure regulators and medicines required in the operating room to Civica's hospitals, which to date include more than 50 health systems, representing 1,200 hospitals and more than 30% of all licensed US hospital beds.
Sandoz is likely to start shipping to Civica later this year.
CivicaScript launches droxidopa for symptomatic neurogenic orthostatic hypotension
Padagis' Naloxone HCl Nasal Spray 4 mg obtains extended shelf-life of 36 months
ANI Pharmaceuticals announces US launch of Nitazoxanide Tablets
Newbury Pharmaceuticals secures approval for Macitentan in Denmark
Mallinckrodt and Endo to merge in USD6.7bn deal to create pharmaceutical leader
Genomma Lab Internacional announces quarterly dividend
Aveva Drug Delivery systems introduces generic Fentanyl Transdermal Patch in US
Independent Pharmacy Cooperative signs cooperation agreement with Legacy Pharmacy Group
ILIKOS Consulting partners with Jordan Center for Pharmaceutical Research
Axsome Therapeutics settles patent litigation with Teva over AUVELITY
Breckenridge Pharmaceutical's Everolimus Tablets for Oral Suspension receive US FDA approval
Newbury Pharmaceuticals secures generic approval for pomalidomide in Denmark
Newbury Pharmaceuticals secures generic approval for Bosutinib in Norway
Guangzhou Fermion Technology partners with Simcere Pharmaceutical